← FDA Medical Device Classifications

Immunocytochemistry Assay, P16/Ki-67

QKF · Class III — High Risk (PMA approval required, life-sustaining) · Hematology · 21 CFR 864.1860

Classification

FDA Product Code
QKF
Device class
Class III — High Risk (PMA approval required, life-sustaining)
Regulation
21 CFR 864.1860
Review panel
PA
Medical specialty
Hematology
Submission type
2
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N

Definition

The p16 and Ki-67 antibody cocktail is a qualitative immunocytochemical assay intended for the simultaneous detection of the p16INK4a (E6H4) and Ki-67 (274-11AC3V1) proteins in cervical specimens collected by a clinician.

Market data

Cleared 510(k) submissions
0
Registered establishments
1

Source

Authoritative
FDA Device Classification database
Machine
JSON-LD · Markdown